- Home
- LEN vs HLN Comparison
LEN vs HLN Comparison
Compare LEN & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEN
- HLN
- Stock Information
- Founded
- LEN 1954
- HLN 2022
- Country
- LEN United States
- HLN United Kingdom
- Employees
- LEN N/A
- HLN N/A
- Industry
- LEN Homebuilding
- HLN Package Goods/Cosmetics
- Sector
- LEN Consumer Discretionary
- HLN Consumer Discretionary
- Exchange
- LEN Nasdaq
- HLN Nasdaq
- Market Cap
- LEN 48.1B
- HLN 43.9B
- IPO Year
- LEN N/A
- HLN N/A
- Fundamental
- Price
- LEN $138.04
- HLN $9.70
- Analyst Decision
- LEN Hold
- HLN Strong Buy
- Analyst Count
- LEN 17
- HLN 2
- Target Price
- LEN $177.54
- HLN $10.48
- AVG Volume (30 Days)
- LEN 2.8M
- HLN 7.2M
- Earning Date
- LEN 12-18-2024
- HLN 08-01-2024
- Dividend Yield
- LEN 1.45%
- HLN 1.62%
- EPS Growth
- LEN 4.22
- HLN N/A
- EPS
- LEN 14.31
- HLN 0.18
- Revenue
- LEN $35,441,452,000.00
- HLN $15,065,004,686.00
- Revenue This Year
- LEN $4.74
- HLN $2.92
- Revenue Next Year
- LEN $8.17
- HLN $2.80
- P/E Ratio
- LEN $9.65
- HLN $26.79
- Revenue Growth
- LEN 3.53
- HLN N/A
- 52 Week Low
- LEN $135.21
- HLN $7.89
- 52 Week High
- LEN $193.80
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- LEN 18.75
- HLN 49.48
- Support Level
- LEN $135.21
- HLN $9.70
- Resistance Level
- LEN $156.76
- HLN $9.95
- Average True Range (ATR)
- LEN 4.27
- HLN 0.12
- MACD
- LEN -2.63
- HLN 0.01
- Stochastic Oscillator
- LEN 6.06
- HLN 38.55
About LEN Lennar Corporation
Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for rent construction and has invested in numerous housing-related technology startups.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.